OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Young adults with nonalcoholic fatty liver disease, defined using the fatty liver index, can be at increased risk of myocardial infarction or stroke
Goh Eun Chung, Eun Ju Cho, Jeong‐Ju Yoo, et al.
Diabetes Obesity and Metabolism (2021) Vol. 24, Iss. 3, pp. 465-472
Closed Access | Times Cited: 21
Goh Eun Chung, Eun Ju Cho, Jeong‐Ju Yoo, et al.
Diabetes Obesity and Metabolism (2021) Vol. 24, Iss. 3, pp. 465-472
Closed Access | Times Cited: 21
Showing 21 citing articles:
Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study
Kyung‐Soo Kim, Sangmo Hong, Kyungdo Han, et al.
BMJ (2024), pp. e076388-e076388
Open Access | Times Cited: 57
Kyung‐Soo Kim, Sangmo Hong, Kyungdo Han, et al.
BMJ (2024), pp. e076388-e076388
Open Access | Times Cited: 57
Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies
Kai En Chan, Elden Yen Hng Ong, Charlotte Hui Chung, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 22, Iss. 3, pp. 488-498.e14
Closed Access | Times Cited: 51
Kai En Chan, Elden Yen Hng Ong, Charlotte Hui Chung, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 22, Iss. 3, pp. 488-498.e14
Closed Access | Times Cited: 51
Nonalcoholic fatty liver disease and cardiovascular diseases: A Mendelian randomization study
Hexiang Peng, Siyue Wang, Mengying Wang, et al.
Metabolism (2022) Vol. 133, pp. 155220-155220
Closed Access | Times Cited: 56
Hexiang Peng, Siyue Wang, Mengying Wang, et al.
Metabolism (2022) Vol. 133, pp. 155220-155220
Closed Access | Times Cited: 56
Association between non-alcoholic fatty liver disease and coronary artery disease outcomes: A systematic review and meta-analysis
Hazem Abosheaishaa, Mai Hussein, Muhammad Ghallab, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2024) Vol. 18, Iss. 1, pp. 102938-102938
Closed Access | Times Cited: 11
Hazem Abosheaishaa, Mai Hussein, Muhammad Ghallab, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2024) Vol. 18, Iss. 1, pp. 102938-102938
Closed Access | Times Cited: 11
The association of metabolic dysfunction-associated steatotic liver disease (MASLD) with the risk of myocardial infarction: a systematic review and meta-analysis
Qiong Lv, Hua-Shan Zhao
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 8
Qiong Lv, Hua-Shan Zhao
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 8
Garlic: A systematic review of the effects on cardiovascular diseases
Vitor Massami Imaizumi, Lucas Fornari Laurindo, Barbara Manzan, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 24, pp. 6797-6819
Closed Access | Times Cited: 37
Vitor Massami Imaizumi, Lucas Fornari Laurindo, Barbara Manzan, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 24, pp. 6797-6819
Closed Access | Times Cited: 37
Cellular interplay between cardiomyocytes and non-myocytes in diabetic cardiomyopathy
Ren Jie Phang, Rebecca H. Ritchie, Derek J. Hausenloy, et al.
Cardiovascular Research (2022) Vol. 119, Iss. 3, pp. 668-690
Open Access | Times Cited: 32
Ren Jie Phang, Rebecca H. Ritchie, Derek J. Hausenloy, et al.
Cardiovascular Research (2022) Vol. 119, Iss. 3, pp. 668-690
Open Access | Times Cited: 32
Global burden of adult non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) has been steadily increasing over the past decades and is expected to persist in the future
Xuan Dong, Jing-Mao Li, Xiaoling Lü, et al.
Translational Gastroenterology and Hepatology (2024) Vol. 9, pp. 33-33
Open Access | Times Cited: 6
Xuan Dong, Jing-Mao Li, Xiaoling Lü, et al.
Translational Gastroenterology and Hepatology (2024) Vol. 9, pp. 33-33
Open Access | Times Cited: 6
Non-alcoholic fatty liver disease increases the risk of cardiovascular disease in young adults and children: a systematic review and meta-analysis of cohort studies
Yan-Lin Liao, Gen-Yuan Zhu, Cheng Chang
Frontiers in Cardiovascular Medicine (2024) Vol. 10
Open Access | Times Cited: 5
Yan-Lin Liao, Gen-Yuan Zhu, Cheng Chang
Frontiers in Cardiovascular Medicine (2024) Vol. 10
Open Access | Times Cited: 5
Comprehensive Review of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease
Kevan Josloff, Jacob Beiriger, Adnan Khan, et al.
Journal of Cardiovascular Development and Disease (2022) Vol. 9, Iss. 12, pp. 419-419
Open Access | Times Cited: 20
Kevan Josloff, Jacob Beiriger, Adnan Khan, et al.
Journal of Cardiovascular Development and Disease (2022) Vol. 9, Iss. 12, pp. 419-419
Open Access | Times Cited: 20
Liver fat as risk factor of hepatic and cardiometabolic diseases
Münevver Demir, Stefan R. Bornstein, Christos S. Mantzoros, et al.
Obesity Reviews (2023) Vol. 24, Iss. 10
Open Access | Times Cited: 12
Münevver Demir, Stefan R. Bornstein, Christos S. Mantzoros, et al.
Obesity Reviews (2023) Vol. 24, Iss. 10
Open Access | Times Cited: 12
Non-alcoholic fatty liver disease (NAFLD) and its association to cardiovascular disease: A comprehensive meta-analysis
Irina Lubomirova Mladenova, Emile Tan, Jing Yong Ng, et al.
JRSM Cardiovascular Disease (2025) Vol. 14
Closed Access
Irina Lubomirova Mladenova, Emile Tan, Jing Yong Ng, et al.
JRSM Cardiovascular Disease (2025) Vol. 14
Closed Access
MICROBIOCENOSIS DISORDERS PROVOKE OXIDATIVE STRESS AS A SIGNIFICANT PATHOGENETIC FACTOR IN NON-ALCOHOLIC STEATOHEPATITIS COMBINED WITH ISCHEMIC HEART DISEASE
I. Skrypnyk, E. V. Ohanisyan, G. S. Maslova, et al.
World of Medicine and Biology (2025) Vol. 21, Iss. 91, pp. 101-101
Closed Access
I. Skrypnyk, E. V. Ohanisyan, G. S. Maslova, et al.
World of Medicine and Biology (2025) Vol. 21, Iss. 91, pp. 101-101
Closed Access
Metabolic dysfunction-associated steatotic liver disease and risk of esophageal cancer in patients with diabetes mellitus: a nationwide cohort study
Yeong Jeong Jeon, Kyungdo Han, Seung Woo Lee, et al.
Diseases of the Esophagus (2024) Vol. 37, Iss. 8
Closed Access | Times Cited: 2
Yeong Jeong Jeon, Kyungdo Han, Seung Woo Lee, et al.
Diseases of the Esophagus (2024) Vol. 37, Iss. 8
Closed Access | Times Cited: 2
Weight loss breaks the bond between nonalcoholic fatty liver disease and cardiovascular diseases: A clinical and epidemiological perspective
Moein Ala, Seyed Parsa Eftekhar
Obesity Reviews (2023) Vol. 24, Iss. 6
Closed Access | Times Cited: 6
Moein Ala, Seyed Parsa Eftekhar
Obesity Reviews (2023) Vol. 24, Iss. 6
Closed Access | Times Cited: 6
Hyperuricemia as an effect modifier of the association between metabolic phenotypes and nonalcoholic fatty liver disease in Chinese population
Jun Zheng, Xuerui Li, Yuan Zhang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 4
Jun Zheng, Xuerui Li, Yuan Zhang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 4
Non-Invasive Serum Markers of Non-Alcoholic Fatty Liver Disease Fibrosis: Potential Tools for Detecting Patients with Cardiovascular Disease
Ling-Zi Chen, Xubin Jing, Xiang Chen, et al.
Reviews in Cardiovascular Medicine (2024) Vol. 25, Iss. 9
Open Access | Times Cited: 1
Ling-Zi Chen, Xubin Jing, Xiang Chen, et al.
Reviews in Cardiovascular Medicine (2024) Vol. 25, Iss. 9
Open Access | Times Cited: 1
Serum PCSK9 Correlates with PTX3 and Apolipoproteins B, A1, and C3 Concentrations in Patients with Type 2 Diabetes
Małgorzata Waluś‐Miarka, Maria Kapusta, Przemysław Miarka, et al.
Cardiovascular Therapeutics (2021) Vol. 2021, pp. 1-9
Open Access | Times Cited: 7
Małgorzata Waluś‐Miarka, Maria Kapusta, Przemysław Miarka, et al.
Cardiovascular Therapeutics (2021) Vol. 2021, pp. 1-9
Open Access | Times Cited: 7
All-Cause and Disease-Specific Mortality in Young Adults with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Nationwide Cohort Study
Jeayeon Park, Goh Eun Chung, Su Jong Yu, et al.
(2024)
Closed Access
Jeayeon Park, Goh Eun Chung, Su Jong Yu, et al.
(2024)
Closed Access
Impacts of Non-alcoholic Fatty Liver Disease on Acute Coronary Syndrome: Evidence and Controversies
Shun‐Yi Shi, Fang Jia, Mengfei Wang, et al.
Current Atherosclerosis Reports (2023) Vol. 25, Iss. 10, pp. 751-768
Open Access
Shun‐Yi Shi, Fang Jia, Mengfei Wang, et al.
Current Atherosclerosis Reports (2023) Vol. 25, Iss. 10, pp. 751-768
Open Access
ASSESSMENT OF CARDIOVASCULAR DISEASE RISK FACTORS IN PATIENTS WITH CORONARY HEART DISEASE COMBINED WITH NONALCOHOLIC FATTY LIVER DISEASE
Yaroslav Y. Ihnatko, М. А. Дербак, П. М. Лукач, et al.
Wiadomości Lekarskie (2023) Vol. 76, Iss. 11, pp. 2378-2382
Closed Access
Yaroslav Y. Ihnatko, М. А. Дербак, П. М. Лукач, et al.
Wiadomości Lekarskie (2023) Vol. 76, Iss. 11, pp. 2378-2382
Closed Access
